非侵襲性出生前検査（NIPT）の世界市場予測（～2024年）...市場調査レポートについてご紹介

1 Introduction (Page No. – 16)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders
2 Research Methodology (Page No. – 19)
2.1 Research Data
2.1.1 Secondary Sources
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Sources
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.2 Market Size Estimation
2.3 Market Breakdown and Data Triangulation
2.4 Market Share Estimation
2.5 Assumptions for the Study
3 Executive Summary (Page No. – 27)
4 Premium Insights (Page No. – 31)
4.1 Non-Invasive Prenatal Testing: Market Overview
4.2 Non-Invasive Prenatal Testing Market, By Application (2019–2024)
4.3 Non-Invasive Prenatal Testing Market Share, By Method & Region (2018)
4.4 Non-Invasive Prenatal Testing Market: Geographic Growth Opportunities
5 Market Overview (Page No. – 34)
5.1 Introduction
5.1.1 Drivers
5.1.1.1 High Risk of Chromosomal Abnormalities With Increasing Maternal Age
5.1.1.2 Growing Preference for Noninvasive Techniques Over Invasive Methods
5.1.1.3 Improving Reimbursement Scenario for NIPT
5.1.1.4 Programs Focusing on Increasing the Awareness of NIPT
5.1.2 Opportunities
5.1.2.1 Untapped Emerging Markets
5.1.3 Challenges
5.1.3.1 Reliability of Test Results, Especially in Obese Women
5.1.3.2 Lack of Skilled Professionals
6 Non-Invasive Prenatal Testing Market, By Product & Service (Page No. – 40)
6.1 Introduction
6.2 Products
6.2.1 Consumables
6.2.1.1 Assay Kits & Reagents
6.2.1.1.1 North America is the Largest Market for Assay Kits & Reagents Segments
6.2.1.2 Disposables
6.2.1.2.1 Use of Disposables to Avoid Contamination is One of the Major Growth Factors for This Segment
6.2.2 Instruments
6.2.2.1 Ultrasound Devices
6.2.2.1.1 Popularity of Ultrasound in Fetal and Embryonic Imaging and Safety has Driven Market Growth
6.2.2.2 Next-Generation Sequencing Systems
6.2.2.2.1 Ngs Systems have Found Rising Use in NIPT
6.2.2.3 Polymerase Chain Reaction Instruments
6.2.2.3.1 Increasing Research in the Field of Prenatal Genetic Testing is Expected to Boost Market Growth
6.2.2.4 Microarrays
6.2.2.4.1 Flexibility of Chips and Short Processing Times have Supported the Use of Microarrays
6.2.2.5 Other Instruments
6.3 Services
6.3.1 North America Shows the Highest Demand for Testing Services
7 Non-Invasive Prenatal Testing Products Market, By Method (Page No. – 53)
7.1 Introduction
7.2 Ultrasound Detection
7.2.1 Ultrasound Detection Segment Dominates the NIPT Products Market
7.3 Biochemical Screening Tests
7.3.1 High Incidence of Genetic Disorders & Increasing Focus on Prenatal Testing to Support Market Growth
7.4 Cell-Free Dna in Maternal Plasma Tests
7.4.1 Cell-Free Dna in Maternal Plasma Tests Segment to Register the Highest CAGR in the Forecast Period
8 Non-Invasive Prenatal Testing Market, By Application (Page No. – 61)
8.1 Introduction
8.2 Trisomy
8.2.1 Trisomy Forms the Largest and Fastest-Growing Application Segment of the NIPT Market
8.3 Microdeletion Syndrome
8.3.1 High Incidence of Microdeletion Syndrome is A Key Factor Driving the Growth of This Application Segment
8.4 Other Applications
9 Non-Invasive Prenatal Testing Products Market, By End User (Page No. – 68)
9.1 Introduction
9.2 Diagnostic Laboratories
9.2.1 Increase in Research Intensity to Drive the Usage of NIPT Products Among Diagnostic Labs
9.3 Hospitals
9.3.1 North America Holds the Major Share of This End-User Segment
10 Non-Invasive Prenatal Testing Market, By Region (Page No. – 74)
10.1 Introduction
10.2 North America
10.2.1 US
10.2.1.1 High Number of Babies Born With Chromosomal Syndromes is A Major Factor Driving the Demand for Non-Invasive Prenatal Testing in the US
10.2.2 Canada
10.2.2.1 Unfavorable Reimbursement Scenario for Non-Invasive Prenatal Testing is A Key Challenge for Market Growth in Canada
10.3 Europe
10.3.1 France
10.3.1.1 Favorable Insurance Coverage for Prenatal Testing to Increase the Adoption of NIPT in France
10.3.2 UK
10.3.2.1 High Incidence of Genetic Abnormalities to Increase the Demand for Prenatal Testing Procedures in the UK
10.3.3 Germany
10.3.3.1 Increasing Healthcare Spending—A Major Factor Contributing to Market Growth in Germany
10.3.4 Rest of Europe
10.4 Asia
10.4.1 High Cost of NIPT Products is A Major Factor Limiting Market Growth in Asia During the Forecast Period
10.5 Rest of the World
11 Competitive Landscape (Page No. – 104)
11.1 Overview
11.2 Market Player Ranking
11.3 Competitive Leadership Mapping – Product Market
11.3.1 Visionary Leaders
11.3.2 Innovators
11.3.3 Dynamic Differentiators
11.3.4 Emerging Players
11.4 Competitive Situation and Trends
11.4.1 Product & Services Launches
11.4.2 Expansions
11.4.3 Acquisitions
11.4.4 Other Strategies
12 Company Profile (Page No. – 112)
(Business Overview, Products and Services Offered, Recent Developments, and MnM View)*
12.1 Illumina, Inc.
12.2 Thermo Fisher Scientific, Inc.
12.3 GE Healthcare (A Wholly Owned Subsidiary of General Electric Company)
12.4 Perkinelmer, Inc.
12.5 Agilent Technologies, Inc.
12.6 Beijing Genomics Institute
12.7 F. Hoffman-La Roche Ltd.
12.8 Laboratory Corporation of America Holdings
12.9 Natera, Inc.
12.10 Yourgene Health
* Business Overview, Products and Services Offered, Recent Developments, and MnM View Might Not Be Captured in Case of Unlisted Companies.
13 Appendix (Page No. – 137)
13.1 Discussion Guide
13.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
13.3 Available Customizations
13.4 Related Reports
13.5 Author Details